A biotech leader with 20 years of industry experience guiding early discovery and development teams across immuno-oncology, pain, and skeletal and cardiac indications. He has advanced programs using diverse therapeutic modalities and helped build two successful startups—CovX (acquired by Pfizer) and Avidity Biosciences (IPO). At Avidity, Hanhua drives cross-functional efforts and has led teams from target validation to clinical candidate nomination.